2 Results for "

sarcoplasmic reticulum Ca-ATPase

" in MedChemExpress (MCE) Product Catalog:
Products (2)

2 Results for "sarcoplasmic reticulum Ca-ATPase" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-Y0258A
CAS No.: 23239-88-5
Research Areas:  

Neurological Disease

Benzocaine hydrochloride is an orally active local anesthetic. Benzocaine hydrochloride non-competitively inhibits the binding of Ca-ATPase to Ca 2+, with an IC50 of 47.1 mM. Benzocaine hydrochloride exerts anesthetic effects by blocking voltage-gated sodium channels. Benzocaine hydrochloride induces methemoglobinemia in various experimental animals .
loading...
    loading...
Cat. No.: HY-165569
CAS No.: 115717-83-4
Target:  

Potassium Channel

Research Areas:  

Neurological Disease

AU-1421 is a potassium ion (K⁺) site-directed regulator that specifically acts on various cation transport ATPases. AU-1421 can distinguish between two different K⁺-sensitive phosphorylation intermediate (E2P) states: for non-K⁺ transport type ATPases (such as the sarcoplasmic reticulum Ca²⁺-ATPase), after binding to AU-1421, it mimics the agonistic effect of K⁺, significantly accelerating the hydrolysis (dephosphorylation) of E2P. For K⁺ transport type ATPases (such as the gastric mucosa H⁺/K⁺-ATPase and the renal Na⁺/K⁺-ATPase), after binding to AU-1421, it inhibits the hydrolysis of E2P, stabilizing the phosphorylated intermediate, thereby blocking the ion transport cycle. AU-1421 can be used to study the mechanism of the potassium ion pump .
loading...
    loading...